Chief of Research and Development
Christopher Winter, Ph.D. is the chief of research and development at Silicon Therapeutics. Over the past 15 years, Dr. Winter has held research leadership positions at pharmaceutical companies and emerging biotechnology. During that time, Dr. Winter has delivered 11 targeted cancer therapies into clinical development.
Dr. Winter joined Sanofi in 2013 as Sanofi Oncology’s head of discovery biology and became site lead in 2015. He joined Sanofi from Blueprint Medicines, where he served as head of biology. The first biologist recruited to Blueprint, Dr. Winter built an outstanding interdisciplinary team and led the company’s first drug discovery project, a first-in-class FGFR4 inhibitor for genomically defined liver cancer. Prior to Blueprint, Dr. Winter held senior research positions at Merck Research Laboratories and Exelixis. He received a doctor of philosophy degree in biochemistry & molecular biophysics from Columbia University in New York and was a post-doctoral fellow at Stanford University in the department of biological sciences in Stanford, Calif.